NeueHealth
NEUE
NEUE was delisted on the 1st of October, 2025.
128 hedge funds and large institutions have $804M invested in NeueHealth in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 24 increasing their positions, 46 reducing their positions, and 18 closing their positions.
205% more call options, than puts
Call options by funds: $1.64M | Put options by funds: $539K
50% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 18
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
6% more funds holding
Funds holding: 121 → 128 (+7)
0.02% less ownership
Funds ownership: 0.89% → 0.88% (-0.02%)
7% less capital invested
Capital invested by funds: $867M → $804M (-$62.9M)
48% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EW
Evoke Wealth
Los Angeles,
California
|
+$1.53M |
| 2 |
Millennium Management
New York
|
+$909K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$857K |
| 4 |
Renaissance Technologies
New York
|
+$807K |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$761K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$3.11M |
| 2 |
D.E. Shaw & Co
New York
|
-$2.81M |
| 3 |
BlackRock
New York
|
-$2.4M |
| 4 |
Two Sigma Investments
New York
|
-$1.5M |
| 5 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$1.43M |
NEUE Hedge Fund Activity: Q2 2022 in Review
128 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in NeueHealth (NEUE) for Q2 2022, worth a combined $804M — down 7.3% from $867M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new NEUE positions and 18 closed out — a net gain of 9 holders — while 24 added to existing stakes and 46 trimmed.
The largest buyer was Evoke Wealth, opening a new position worth an estimated $1.53M. The largest seller was Boston Partners, exiting entirely with an estimated $3.11M sold.
- 128 institutional investors held NeueHealth (NEUE) as of Q2 2022, up from 121 in Q1 2022.
- Funds reported $804M of NeueHealth stock for Q2 2022, down 7.3% quarter-over-quarter.
- 27 funds opened new NeueHealth positions in Q2 2022 and 18 closed out, a net change of +9 holders.
- The largest NeueHealth buyer in Q2 2022 was Evoke Wealth, an estimated $1.53M added.
- The largest NeueHealth seller in Q2 2022 was Boston Partners, an estimated $3.11M sold.
Based on aggregated 13F filings for Q2 2022.